Biotech Startups

Genemod offers a lab management platform that unifies electronic lab notebook (ELN), LIMS, inventory, and equipment in a single data model, with AI agents that plan and execute experiments and produce audit-ready, signed records. It serves scientific research teams across settings from discovery labs to regulated manufacturing, including protein therapeutics, cell line development, and academic and institute labs.

1 investor

GeneNeer develops advanced gene-editing platforms to accelerate the development of crop seeds with improved yield, growth, and nutritional value for the agricultural supply chain. The company uses proprietary methods offering superior efficiency, precision, speed and affordability compared to existing CRISPR and similar technologies.

1 investor

1 investor

Generable develops statistical and computational models for drug development and healthcare decision-making, leveraging Bayesian methods and probabilistic modeling. The company serves pharmaceutical and biotech organizations in developing safer and more efficient therapeutic interventions.

1 investor

General Biotechnologies manufactures peptide therapeutics by genetically programming edible microbes to synthesise molecules, aiming to produce them at lower cost. It focuses on reviving clinically proven but discontinued off-patent peptides as low-cost oral drugs, including an oral GLP-1, and partners with pharma companies to bring shelved assets back as oral formulations.

1 investor

Generate Life Sciences was a reproductive, newborn stem cell, and genetic services company offering products and services to help families grow and protect their families. It has been acquired by CooperSurgical.

1 investor

A biotech-focused investment firm that creates and backs companies in the future of medicine.

1 investor

GenesisTissue is a 3D bioprinting company that designs and manufactures personalized regenerative tissue implants for humans. It operates in the regenerative medicine and medical implant space.

1 investor

Adapsyn Bioscience is a biotechnology company that uses proprietary algorithms and artificial intelligence to analyze genomic and metabolomic data from microbes in order to discover novel small molecule natural product drug candidates.

1 investor

GeneTech provides non-invasive prenatal testing (NIPT) using fetal cell-free DNA from maternal blood, along with clinical laboratory testing services, offered to certified medical institutions in Japan. It introduced NIPT in Japan in 2013 and runs a domestic analysis lab, serving pregnant patients and their families through partner hospitals.

1 investor

Genetica is an artificial intelligence-powered genetic testing company that analyzes hundreds of genes to provide scientific insights about physical traits, behavior, intelligence, and health risks for Asian populations. The company partners with leading genome sequencing organizations and aims to optimize personal development plans and protect individual and family health.

1 investor

Genetic Networks is a biotech company conducting discovery research on a conserved biological network to generate findings applicable across diseases, drugs, and therapeutic targets in medicine.

1 investor

Genetix Biotherapeutics develops gene addition therapies that use a patient's own cells to treat the underlying cause of rare diseases with a single dose, with a focus on hematology conditions such as sickle cell disease. The company has three FDA-approved one-time treatments for rare diseases.

1 investor

Genevation develops personalized mRNA cancer vaccines using an AI-driven neoantigen discovery platform and cell-free manufacturing, with pre-clinical programs targeting lung, colon, and skin cancers. The biotech company serves precision oncology and is based in the UK, expanding into the USA.

1 investor

GENEWIZ provides sequencing, synthesis, and molecular biology services for research, clinical, and therapeutic applications, serving academic institutions, biotech companies, and pharmaceutical organizations.

1 investor

Geneyx offers a genomic data analysis platform for secondary and tertiary interpretation of NGS data, including exome, whole genome sequencing, and gene panels, with AI/ML-driven variant interpretation, automated annotation, and customizable reporting. It serves genetics labs, life-science companies, clinical researchers, and research institutes worldwide, integrating with LIMS and existing bioinformatic pipelines.

1 investor

GenieBiome (G-NiiB) develops microbiome-modifying technology and therapeutic candidates supported by clinical trials, using next-generation sequencing. The company focuses on treating human diseases through microbiome-based solutions.

1 investor

GeniPhys develops Collymer, a patented polymerizable (scaffold-forming) collagen technology used to design and fabricate collagen biomaterials for tissue restoration and regeneration. Its materials target regenerative medicine applications including soft tissue, cardiovascular, musculoskeletal, and orthopedic replacements, as well as delivery of pharmaceutical and cell-based therapies and device coatings.

1 investor

Genetic medicines company developing targeted nucleic acid therapeutics via a gene monoclonal antibody platform.

1 investor

1 investor

Genoa Instruments develops optical microscopy hardware and software, including PRISM, a Photon-Resolved Image Scanning Microscope built on SPAD array technology for quantitative fluorescence imaging. It targets researchers performing super-resolution and lifetime imaging studies on living biological samples, and is a spin-off of the Istituto Italiano di Tecnologia in Italy.

1 investor

GenoGra develops a pangenomic graph software platform for secondary genomic analysis, using graph-based modeling and hardware acceleration to detect complex and structural variants that linear reference methods miss. It targets researchers and organizations working in population genomics and genomic interpretation.

1 investor

Genomadix develops the Cube, a point-of-care PCR platform for real-time molecular testing in precision medicine and environmental applications. The company commercializes FDA-cleared genotyping tests and offers its open platform for partnerships with assay developers and clinical laboratories.

1 investor

Genomate Health develops an AI-powered clinical decision support system for precision oncology that analyzes a patient's molecular profile to produce evidence-based treatment rankings for physicians. Its Genomate platform combines oncology, genomics, and computational reasoning to support personalized cancer treatment decisions.

1 investor